Laboratory testing for the new oral anticoagulants: a review of current practice

被引:32
作者
Favaloro, Emmanuel J. [1 ]
Bonar, Roslyn [2 ]
Butler, Jennifer [3 ]
Marsden, Katherine [4 ]
机构
[1] Westmead Hosp, ICPMR, Dept Haematol, Westmead, NSW, Australia
[2] RCPA Haematol QAP, St Leonards, NSW, Australia
[3] Monash Med Ctr, Southern Cross Pathol, Haematol Dept, Clayton, Vic 3168, Australia
[4] Royal Hobart Hosp, Pathol Serv, Hobart, Tas, Australia
关键词
COAGULATION ASSAYS; DABIGATRAN; RIVAROXABAN;
D O I
10.1097/PAT.0b013e328360f02d
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
[No abstract available]
引用
收藏
页码:435 / 437
页数:3
相关论文
共 13 条
[11]   Laboratory assessment of new anticoagulants [J].
Samama, Meyer M. ;
Guinet, Celine .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 (05) :761-772
[12]   Position paper on laboratory testing for patients taking new oral anticoagulants. Consensus document of FCSA, SIMeL, SIBioC and CISMEL [J].
Tripodi, Armando ;
Di Iorio, Giancarlo ;
Lippi, Giuseppe ;
Testa, Sophie ;
Manotti, Cesare .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2012, 50 (12) :2137-2140
[13]   Dabigatran etexilate - a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity [J].
van Ryn, Joanne ;
Stangier, Joachim ;
Haertter, Sebastian ;
Liesenfeld, Karl-Heinz ;
Wienen, Wolfgang ;
Feuring, Martin ;
Clemens, Andreas .
THROMBOSIS AND HAEMOSTASIS, 2010, 103 (06) :1116-1127